JP Morgan Chase
DRTS icon

JP Morgan Chase’s Alpha Tau Medical DRTS Stock Holding History

JP Morgan Chase’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9K Buy
+5,020
New +$35.4K ﹤0.01% 6361
2023
Q4 		– Sell
-39,656
Closed -$150K – 7592
2023
Q3 		$150K Buy
39,656
+476
+1% +$1.74K ﹤0.01% 5239
2023
Q2 		$171K Sell
39,180
-19,397
-33% -$69.5K ﹤0.01% 5169
2023
Q1 		$168K Sell
58,577
-771
-1% -$2.69K ﹤0.01% 5157
2022
Q4 		$189K Sell
59,348
-15,768
-21% -$65.3K ﹤0.01% 5058
2022
Q3 		$439K Sell
75,116
-2,271
-3% -$20K ﹤0.01% 4548
2022
Q2 		$697K Buy
+77,387
New +$693K ﹤0.01% 4347

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

JP Morgan Chase's DRTS Position: Q1 2026 in Review

JP Morgan Chase opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 5,020 shares worth $32.9K. The stake represents ﹤0.01% of the portfolio and ranks #6361 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in DRTS as recently as Q3 2023.

JP Morgan Chase first reported a position in DRTS in Q2 2022 and has held it in 7 quarters since. The position peaked at $697K in Q2 2022. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • JP Morgan Chase held 5,020 shares of Alpha Tau Medical worth $32.9K as of Q1 2026.
  • Alpha Tau Medical was a new JP Morgan Chase position in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6361 holding.
  • JP Morgan Chase first reported a position in Alpha Tau Medical in Q2 2022 and has held it in 7 quarters since.
  • JP Morgan Chase's Alpha Tau Medical position peaked at $697K in Q2 2022.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.